A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome
Kiren Gill, Harry Horsley, Sheela Swamy and 2 more
BMC Urology · 2021
doi:10.1186/s12894-021-00809-4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Background Contemporary studies have discredited the methods used to exclude urinary tract infection (UTI) when treating overactive bladder (OAB). Thus we must revisit the OAB phenotype to check that UTI has not been overlooked. Aims To examine the differences in urinary cytokines IL6 and lactoferrin in OAB patients compared to controls, with references to microscopy of urine and enhanced quantitative urine culture. Methods A blinded, prospective cohort study with normal controls using six repeated measures, achieved two-monthly, over 12 months. Results The differences between patients and controls in urine IL6 (F = 49.0, p <.001) and lactoferrin (F = 228.5, p <.001) were significant and of a magnitude to have clinical implications. These differences were for lactoferrin correlated to symptoms (9.3, p =.003); for both to pyuria (IL6 F = 66.2, p <.001, Lactoferrin F = 73.9, p <.001); and for IL6 microbial abundance (F = 5.1, p =.024). The pathological markers had been missed by urinary dipsticks and routine MSU culture. Conclusion The OAB phenotype may encompass patients with UTI that is being overlooked because of the failure of standard screening methods.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.